25 related articles for article (PubMed ID: 2877065)
1. Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors.
Hsu CH; Cui Z; Mumper RJ; Jay M
AAPS PharmSciTech; 2003; 4(3):E32. PubMed ID: 14621964
[TBL] [Abstract][Full Text] [Related]
2. Effect of egg yolk phospholipids plasma elimination and tissue distribution of coenzyme Q10 administered in an emulsion to rats.
Yamaguchi H; Watanabe K; Hayashi M; Awazu S
J Pharm Pharmacol; 1984 Nov; 36(11):766-7. PubMed ID: 6150982
[TBL] [Abstract][Full Text] [Related]
3. 11C-coenzyme Q10: a new myocardial imaging tracer for positron emission tomography.
Ishiwata K; Miura Y; Takahashi T; Kawashima K; Yanai K; Monma M; Ido T
Eur J Nucl Med; 1985; 11(5):162-5. PubMed ID: 3877633
[TBL] [Abstract][Full Text] [Related]
4. The effects of emulsifying agents on disposition of lipid-soluble drugs included in fat emulsion.
Suzuki Y; Masumitsu Y; Okudaira K; Hayashi M
Drug Metab Pharmacokinet; 2004 Feb; 19(1):62-7. PubMed ID: 15499171
[TBL] [Abstract][Full Text] [Related]
5. Release of lipoprotein lipase to plasma by triacylglycerol emulsions. Comparison to the effect of heparin.
Hultin M; Bengtsson-Olivecrona G; Olivecrona T
Biochim Biophys Acta; 1992 Apr; 1125(1):97-103. PubMed ID: 1567914
[TBL] [Abstract][Full Text] [Related]
6. Lipid emulsions of palmitoylrhizoxin: effects of composition on lipolysis and biodistribution.
Kurihara A; Shibayama Y; Mizota A; Yasuno A; Ikeda M; Sasagawa K; Kobayashi T; Hisaoka M
Biopharm Drug Dispos; 1996 May; 17(4):331-42. PubMed ID: 8743404
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing the tissue distribution of coenzyme Q10 intravenously administered in an emulsion to rats: emulsifying agents and lipoprotein lipase activity.
Kimura A; Yamaguchi H; Watanabe K; Hayashi M; Awazu S
J Pharm Pharmacol; 1986 Sep; 38(9):659-62. PubMed ID: 2877065
[TBL] [Abstract][Full Text] [Related]
8. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.
Bhagavan HN; Chopra RK
Mitochondrion; 2007 Jun; 7 Suppl():S78-88. PubMed ID: 17482886
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic treatment with coenzyme Q10 in patients undergoing cardiac surgery: could an antioxidant reduce complications? A systematic review and meta-analysis.
de Frutos F; Gea A; Hernandez-Estefania R; Rabago G
Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):254-9. PubMed ID: 25344142
[TBL] [Abstract][Full Text] [Related]
10. The uptake and distribution of coenzyme Q10.
Miles MV
Mitochondrion; 2007 Jun; 7 Suppl():S72-7. PubMed ID: 17446143
[TBL] [Abstract][Full Text] [Related]
11. Coenzyme Q10 and statins: biochemical and clinical implications.
Littarru GP; Langsjoen P
Mitochondrion; 2007 Jun; 7 Suppl():S168-74. PubMed ID: 17482884
[TBL] [Abstract][Full Text] [Related]
12. [Study of Formulation Development Based on the Pharmacokinetic Properties of Functional Food Components].
Sato Y
Yakugaku Zasshi; 2019; 139(3):341-347. PubMed ID: 30828009
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
